Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 8, 2011, Pages 3276-3281

  Boeckel, Jes Niels ^a   Guarani, Virginia ^a   Koyanagi, Masamichi ^a   Roexe, Tino ^a   Lengeling, Andreas ^b   Schermuly, Ralph T ^c,d   Gellert, Pascal ^d   Braun, Thomas ^d   Zeiher, Andreas ^a   Dimmeler, Stefanie ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Hypoxia; sFlt1

Indexed keywords

CELL SURFACE RECEPTOR; JUMONJI DOMAIN CONTAINING PROTEIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA SPLICING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79952768708     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008098108     Document Type: Article

References (36)

1. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932-936.
2. Tsukada Y, et al. (2006) Histone demethylation by a family of JmjC domain-containing proteins. Nature 439:811-816. (Pubitemid 43255695)
3. Hewitson KS, et al. (2002) Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277:26351-26355. (Pubitemid 34967127)
4. Lando D, et al. (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466-1471. (Pubitemid 34686328)
5. Pollard PJ, et al. (2008) Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J 416:387-394.
6. Wellmann S, et al. (2008) Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun 372:892-897.
7. Sar A, Ponjevic D, Nguyen M, Box AH, Demetrick DJ (2009) Identification and characterization of demethylase JMJD1A as a gene upregulated in the human cellular response to hypoxia. Cell Tissue Res 337:223-234.
8. Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P (2008) The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem 283:36542-36552.
9. Krieg AJ, et al. (2010) Regulation of the histone demethylase JMJD1A by hypoxiainducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol 30:344-353.
10. Xia X, et al. (2009) Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 106: 4260-4265.
11. Fadok VA, et al. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405:85-90. (Pubitemid 30321820)
12. Cikala M, et al. (2004) The phosphatidylserine receptor from Hydra is a nuclear protein with potential Fe(II) dependent oxygenase activity. BMC Cell Biol 5:26.
13. Cui P, Qin B, Liu N, Pan G, Pei D (2004) Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals. Exp Cell Res 293:154-163. (Pubitemid 38064422)
14. Krieser RJ, et al. (2007) The Drosophila homolog of the putative phosphatidylserine receptor functions to inhibit apoptosis. Development 134:2407-2414. (Pubitemid 47074135)
15. Mitchell JE, et al. (2006) The presumptive phosphatidylserine receptor is dispensable for innate anti-inflammatory recognition and clearance of apoptotic cells. J Biol Chem 281:5718-5725. (Pubitemid 43847670)
16. Tibrewal N, Liu T, Li H, Birge RB (2007) Characterization of the biochemical and biophysical properties of the phosphatidylserine receptor (PS-R) gene product. Mol Cell Biochem 304:119-125. (Pubitemid 47456858)
17. Böse J, et al. (2004) The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J Biol 3(4):15.
18. Chang B, Chen Y, Zhao Y, Bruick RK (2007) JMJD6 is a histone arginine demethylase. Science 318:444-447. (Pubitemid 47614528)
19. Webby CJ, et al. (2009) Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 325(5936):90-93.
20. Schneider JE, et al. (2004) Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique. BMC Dev Biol 4(1):16.
21. Maynard SE, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658. (Pubitemid 36278583)
22. Wu FT, et al. (2010) A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14:528-552.
23. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - In control of vascular function. Nat Rev Mol Cell Biol 7:359-371.
24. Kendall RL, Thomas KA (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90: 10705-10709. (Pubitemid 23347111)
25. Thomas CP, Andrews JI, Liu KZ (2007) Intronic polyadenylation signal sequences and alternate splicing generate human soluble Flt1 variants and regulate the abundance of soluble Flt1 in the placenta. FASEB J 21:3885-3895. (Pubitemid 350232346)
26. Sela S, et al. (2008) A novel human-specific soluble vascular endothelial growth factor receptor 1: Cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res 102:1566-1574.
27. Heydarian M, et al. (2009) Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta 30:250-255.
28. Thomas CP, et al. (2009) A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J Clin Endocrinol Metab 94:2524-2530.
29. Wu FT, et al. (2010) A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14:528-552.
30. Bainbridge JW, et al. (2002) Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther 9:320-326. (Pubitemid 34285145)
31. Potente M, et al. (2007) SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21:2644-2658. (Pubitemid 47607673)
32. Gellert P, Uchida S, Braun T (2009) Exon Array Analyzer: A web interface for Affymetrix exon array analysis. Bioinformatics 25:3323-3324.
33. Irizarry RA, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
34. Clark TA, et al. (2007) Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 8:R64.
35. Korff T, Augustin HG (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143:1341-1352. (Pubitemid 28559834)
36. Schermuly RT, et al. (2007) Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: Target for reverse-remodeling therapy. Circulation 115:2331-2339. (Pubitemid 46685901)